Pulmonary Arterial Hypertension (PAH) Highlights from CHEST 2020
| Overview / Abstract: |
Although CHEST 2020 was not a live, in-person meeting, new information and data regarding pulmonary arterial hypertension (PAH) will still be published but will not be easily accessible to the care team involved in the diagnosis and management of patients with this rare disease who need to know and incorporate the latest information into patient care. This CME activity highlights the latest research on PAH to help clinicians keep up to date on the most efficient ways to manage their patients. |
|
Expiration |
Mar 01, 2022 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Online, Podcast, Seminar, Webinar / Webcast / Video |
|
Credits / Hours |
0.25 |
|
Accreditation |
AACME, Inc |
|
Is This Activity Certified for "Live" Credit? |
YES |
|
Presenters / Authors / Faculty |
Richard N Channick, MD |
|
Activity Specialities / Related Topics |
Rheumatology / Arthritis, Radiology / Imagery / Nuclear Medicine, Pulmonary Medicine / COPD, Internal Medicine, Family Medicine |
|
Sponsors / Supporters / Grant Providers |
Actelion Pharmaceuticals US, Inc. |
|
Keywords / Search Terms |
CheckRare PAH, CHEST 2020, pulmonary arterial hypertension, rare disease, rare pulmonary disorder, CheckRare, Actelion, Richard N Channick MD, David Geffen School of Medicine at UCLA, Pulmonary Vascular Disease Program, Ronald Reagan UCLA Medical Center, pulmonary hypertension, blood vessels in lungs, pulmonology, rare progressive disorder, high blood pressure, hypertension Free CE CME Live CE CME |
|